Xvivo Perfusion AB (publ) (XVIPF)

Market Cap	726.91M
Revenue (ttm)	86.34M
Net Income (ttm)	3.17M
Shares Out	n/a
EPS (ttm)	0.10
PE Ratio	229.07
Forward PE	73.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	482
Open	23.25
Previous Close	23.43
Day's Range	23.25 - 23.25
52-Week Range	16.98 - 44.00
Beta	1.86
RSI	52.56
Earnings Date	Jan 27, 2026

About Xvivo Perfusion AB

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 190
• Stock Exchange: OTCMKTS
• Ticker Symbol: XVIPF

Financial Performance

In 2024, Xvivo Perfusion AB's revenue was 822.42 million, an increase of 37.63% compared to the previous year's 597.54 million. Earnings were 172.18 million, an increase of 87.52%.

Financial numbers in SEK